Aligos TherapeuticsALGS
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 49 institutions reported holding Aligos Therapeutics Inc. (ALGS) in their 13F filings, unchanged from Q1 2024. 8 opened new positions and 7 sold out. The largest holders were Armistice Capital, LLC ($2.5M), EcoR1 Capital, LLC ($2.2M) and Deep Track Capital, LP ($2.1M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Aligos Therapeutics Inc.
- CUSIP
- 01626L105
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $324K |
| Exits | 7 | $175K |
All 13F filers, Q1 2024 → Q2 2024: 6,375,545 shares bought and 2,454,818 shares sold, net +3,920,727 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 49 holders
| Armistice Capital, LLC | 0.07% | Add +5.3% | 7,256,410 | $2.5M |
| EcoR1 Capital, LLC | 0.07% | No change | 6,389,468 | $2.2M |
| Deep Track Capital, LP | 0.06% | No change | 6,102,770 | $2.1M |
| Adage Capital Partners Gp, L.L.C. | 0.00% | Add +102.9% | 5,000,000 | $1.8M |
| Vivo Capital, LLC | 0.11% | No change | 3,547,030 | $1.2M |
| HHLR Advisors, LTD. | 0.03% | Add +63.8% | 3,121,689 | $1.1M |
| Baker Bros. Advisors LP | 0.01% | No change | 2,076,400 | $727K |
| Tang Capital Management LLC | 0.06% | No change | 1,650,000 | $578K |
| Vanguard Group Inc. | 0.00% | Add +57.5% | 1,595,359 | $558K |
| Versant Venture Management, LLC | 0.66% | Reduce -37.2% | 1,457,937 | $510K |
| Opaleye Management Inc. | 0.10% | Reduce -22.7% | 1,260,000 | $441K |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.01% | Add +100.0% | 1,000,000 | $350K |
| Acadian Asset Management LLC | 0.00% | Add +26.1% | 829,485 | $289K |
| Bank of America Corp. | 0.00% | Reduce -28.9% | 816,029 | $286K |
| Renaissance Technologies | 0.00% | Reduce -4.9% | 768,839 | $269K |
| Pivotal bioVenture Partners Investment Advisor LLC | 0.20% | No change | 743,215 | $260K |
| Newtyn Management, LLC | 0.05% | Reduce -40.1% | 719,287 | $252K |
| Silverarc Capital Management, LLC | 0.06% | No change | 655,515 | $229K |
| Woodline Partners LP | 0.00% | New | 531,204 | $186K |
| Geode Capital Management, LLC | 0.00% | Add +8.8% | 405,694 | $142K |
| Alyeska Investment Group, L.P. | 0.00% | New | 284,233 | $99K |
| Citadel Advisors | 0.00% | Reduce -2.9% | 277,363 | $97K |
| BlackRock Inc. | 0.00% | Reduce -25.1% | 227,406 | $80K |
| State Street Corp. | 0.00% | Add +10.0% | 107,123 | $37K |
| Northern Trust Corp. | 0.00% | Reduce -0.1% | 91,950 | $32K |
| LMR Partners LLP | 0.00% | New | 50,000 | $18K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +479.4% | 46,476 | $16K |
| XTX Topco Ltd | 0.00% | Reduce -20.6% | 35,644 | $12K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 31,383 | $11K |
| Millennium Management | 0.00% | Reduce -73.0% | 29,881 | $10K |
| Choate Investment Advisors | 0.00% | No change | 24,000 | $8K |
| Prudential Financial Inc. | 0.00% | New | 19,600 | $7K |
| HarbourVest Partners LLC | 0.00% | No change | 18,783 | $7K |
| Two Sigma Investments, LP | 0.00% | Add +0.4% | 18,706 | $7K |
| Cwm, LLC | 0.00% | No change | 16,891 | $6K |
| ZWJ Investment Counsel Inc. | 0.00% | No change | 14,500 | $5K |
| Jane Street Group, LLC | 0.00% | New | 13,666 | $5K |
| Zullo Investment Group, Inc. | 0.00% | No change | 13,000 | $5K |
| Virtu Financial LLC | 0.00% | New | 12,306 | $4K |
| HighTower Advisors, LLC | 0.00% | New | 10,000 | $4K |
| Creative Planning | 0.00% | Reduce -35.3% | 10,050 | $4K |
| Osaic Holdings, Inc. | 0.00% | New | 5,500 | $2K |
| Morgan Stanley | 0.00% | No change | 3,300 | $1K |
| JPMorgan Chase & Co. | 0.00% | No change | 677 | $237 |
| UBS Group AG | 0.00% | Reduce -96.7% | 362 | $127 |
| Elevation Wealth Partners, LLC | 0.00% | No change | 100 | $35 |
| Royal Bank of Canada | 0.00% | Add +312.1% | 511 | $0 |
| Simplex Trading, LLC | 0.00% | Reduce -81.2% | 208 | $0 |
| Qube Research & Technologies Ltd | 0.00% | No change | 2 | $0 |
"% of holder's portfolio" is ALGS's weight in each manager's 13F, not the share of Aligos Therapeutics Inc. the manager owns.